Asthma Clinical Case Review

"Because of patient's severity of asthma based off of symptoms and low FEV1, frequent oral steroid use and frequent emergency room visits, I recommended biological therapy for severe asthma.

We discussed biological therapeutic options, including anti IgE, anti IL5 and anti IL4 receptor alpha, including different mechanisms of action, side effect profiles, frequency of injections and number of injections. Because patient preferred home use of an asthma biologic and had history of eczema, patient was started on Dupilumab (Dupixent; Sanofi and Regeneron Pharmaceuticals, Inc.)."